Evaluation of quality of life and prognostic scales in patients with chronic obstructive pulmonary disease
https://doi.org/10.18093/0869-0189-2016-26-4-473-480
Abstract
This study was aimed at assessment of vaccination effects on quality of life and main prognostic scores in COPD patients. Methods. The study involved 362 male patients with COPD. Vaccination was done using13-valent conjugate pneumococcal vaccine Prevenar-13 (PCV-13) and polyvalent pneumococcal vaccine Pneumo-23 (PPV23). Quality of life was assessed using the Russian version of SRGQ and CAT questionnaire. Prognostic BODE, DOSE and ADO scores were calculated. Results. Vaccination with PCV13 and PPV23 was associated with improvement in quality of life in 1 year after vaccination, though this effect of PPV23 decreased to the 3rd year. Quality of life questionnaires help to assess the therapeutic strategy chosen both in early and delayed follow-up. BODE, DOSE, and ADO scores have demonstrated a reliable and statistically significant decrease in 1 year after vaccination; for PCV13, this effect maintained in 3 years after vaccination. Conclusion. Vaccination with PCV13 could reduce total 3-year healthcare expenses to 11,357 RUB (78%), partly due to long-term maintenance of the effect of vaccination. This is an important advantage of PCV13 over PPV23 both from economic and clinical points of view.
About the Authors
G. L. Ignatova
South Ural State Medical University, Healthcare Ministry of Russia: 64, Vorovskogo str., Chelyabinsk, 454092, Russia
Russian Federation
Russian Federation
MD, Professor, Head of Department of Therapy, Faculty of Postgraduate Physician Training, South Ural State Medical University, Healthcare Ministry of Russia; tel.: (351) 742-66-40;
V. N. Antonov
South Ural State Medical University, Healthcare Ministry of Russia: 64, Vorovskogo str., Chelyabinsk, 454092, Russia
Russian Federation
Russian Federation
PhD, Associate Professor at Department of Therapy, Faculty of Postgraduate Physician Training, South Ural State Medical University, Healthcare Ministry of Russia; tel.: (351) 742-66-40;
O. V. Rodionova
South Ural State Medical University, Healthcare Ministry of Russia: 64, Vorovskogo str., Chelyabinsk, 454092, Russia
Russian Federation
Russian Federation
PhD, Associate Professor at Institute of Postgraduate Physician Training, South Ural State Medical University, Healthcare Ministry of Russia; tel.: (351) 742-66-40
I. V. Grebneva
South Ural State Medical University, Healthcare Ministry of Russia: 64, Vorovskogo str., Chelyabinsk, 454092, Russia
Russian Federation
Russian Federation
PhD, Associate Professor at Institute of Postgraduate Physician Training, South Ural State Medical University, Healthcare Ministry of Russia; tel.: (351) 742-66-40;
M. S. Bel'sner
South Ural State Medical University, Healthcare Ministry of Russia: 64, Vorovskogo str., Chelyabinsk, 454092, Russia
Russian Federation
Russian Federation
PhD student at Department of Therapy, Institute of Postgraduate Physician Training, South Ural State Medical University, Healthcare Ministry of Russia; tel.: (351) 742-66-40
References
1. Kolosov V.P., Trofimova A.Yu., Naryshkina S.V. Quality of life of patients with chronic obstructive pulmonary disease. Blagoveshchensk; 2011 (in Russian).
2. Chuchalin A.G. Chronic obstructive pulmonary disease, 2009. results of first decade of the new millenium. Consilium Medicum. Suppl. 2009: 3 (in Russian).
3. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD), 2016.
4. ГлобGlobal Strategy on Diagnosis, Treatment and Prevention of Chronic Obstructive Pulmonary Disease (update 2011). Translated from English (ed. by A.S.Belevskiy). Moscow: RRO; 2012 (in Russian).
5. Sinopal'nikov A.I., Zaytsev A.A. Current view on pharmacotherapy of acute exacerbations of chronic obstructive pulmonary disease. Meditsinskie novosti. 2010; 10: 13–17 (in Russian).
6. Dvoretskiy L.I. Infectious Exacerbation of COPD. Lechashchiy vrach. 2007; 3: 80–84 (in Russian).
7. Chuchalin A.G.et al. A Survey of Chronic Respiratory Disease and Their Risk Factors in 12 Regions of Russian Federation. Available at: www.medi.ru (in Russian).
8. Chuchalin A.G., Sinopal'nikov A.I., Kozlov R.S., et al. Infectious Exacerbation of COPD. Practical Guidelines on Diagnosis, Treatment and Prevention. Moscow; 2005 (in Russian).
9. Avdeev S.N. Could recent medications modify the course of COPD? Terapevticheskiy arkhiv. 2008; 8: 80–86 (in Russian).
10. Novik A.A., Ionova T.I. A Guideline on Assessment of Quality of Life in Medicine. Moscow: OLMA Media Grupp; 2007 (in Russian).
11. The MRC breathlessness scale addapted from Fletcher C.M, Discussion on the Diagnosis of Pulmonary Emphysema. J. R. Soc. Med. September 1952; 45: 576–586.
12. Belevskiy A.S. CAT-test: to share a common language with the patient. In: The 19th Russian National Congress on respiratory diseases. The Abstract Book. Moscow; 2009: 225 (in Russian).
13. St. George’s Hospital Respiratory Questionnaire – URL: http://www.healthstatus.sgul.ac.uk (Accessed at 01.07.2016).
14. Ignatova G.L., Antonov V.N., Rodionova O.V. Economic evaluation of vaccination of patients with chronic obstructive pulmonary disease and coronary heart disease. Pul'monologiya. 2015; 3: 312–319 (in Russian).
15. Kostinov M.P., Protasov A.D. Perspective results of vaccination of adult patients with chronic obstructive pulmonary disease using pneumococcal 13-valent conjugate vaccine. Pul'monologiya. 2014; 4: 57–62 (in Russian).
16. Protasov A.D., Kostinov M.P., et al. A choice of optimal pneumococcal vaccination schedule of patients with chronic obstructive pulmonary disease from immunological and clinical point of view. Terapevticheskiy arkhiv. 2016; 5: 62–69 (in Russian).
Review
For citations:
Ignatova G.L., Antonov V.N., Rodionova O.V., Grebneva I.V., Bel'sner M.S. Evaluation of quality of life and prognostic scales in patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2016;26(4):473-480. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-4-473-480
Views:
1026
Email this article 